Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$6.2 - $7.87 $3,720 - $4,722
-600 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.13 - $7.89 $3,078 - $4,734
600 New
600 $4,000
Q4 2020

Feb 12, 2021

SELL
$3.9 - $11.25 $99,067 - $285,772
-25,402 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$2.03 - $2.29 $51,566 - $58,170
25,402
25,402 $0

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $9.77M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.